Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.

Vaccination of malaria-naive humans with recombinant RTS,S/AS02, which includes the C-terminus of the circumsporozoite protein (CS), has been shown to induce strong T cell responses to both the whole protein antigen and to peptides from CS. Here we show that strong T cell responses were also observe...

Full description

Bibliographic Details
Main Authors: Pinder, M, Reece, W, Plebanski, M, Akinwunmi, P, Flanagan, K, Lee, E, Doherty, T, Milligan, P, Jaye, A, Tornieporth, N, Ballou, R, McAdam, K, Cohen, J, Hill, A
Format: Journal article
Language:English
Published: 2004
_version_ 1826289518306656256
author Pinder, M
Reece, W
Plebanski, M
Akinwunmi, P
Flanagan, K
Lee, E
Doherty, T
Milligan, P
Jaye, A
Tornieporth, N
Ballou, R
McAdam, K
Cohen, J
Hill, A
author_facet Pinder, M
Reece, W
Plebanski, M
Akinwunmi, P
Flanagan, K
Lee, E
Doherty, T
Milligan, P
Jaye, A
Tornieporth, N
Ballou, R
McAdam, K
Cohen, J
Hill, A
author_sort Pinder, M
collection OXFORD
description Vaccination of malaria-naive humans with recombinant RTS,S/AS02, which includes the C-terminus of the circumsporozoite protein (CS), has been shown to induce strong T cell responses to both the whole protein antigen and to peptides from CS. Here we show that strong T cell responses were also observed in a semi-immune population in The Gambia, West Africa. In a Phase I study, 20 adult male volunteers, lifelong residents in a malaria-endemic region, were given three doses of RTS,S/AS02 at 0, 1 and 6 months. Responses to RTS,S, hepatitis B surface antigen and peptides from CS were tested using lymphocyte proliferation, interferon (IFN)-gamma production in microcultures, and IFN-gamma ex vivo and cultured ELISPOT, before and after vaccination. Cytotoxic responses were tested only after vaccination and none were detected. Before vaccination, the majority of the volunteers (15/20) had detectable responses in at least one of the tests. After vaccination, responses increased in all assays except cytotoxicity. The increase was most marked for proliferation; all donors responded to RTS,S after the third dose and all except one donor responded to at least one peptide after the second or third dose. There was a lack of close association of peptide responses detected by the different assays, although in microcultures IFN-gamma responses were found only when proliferative responses were high, and responses by cultured ELISPOT and proliferation were found together more frequently after vaccination. We have therefore identified several peptide-specific T cell responses induced by RTS,S/AS02 which provides a mechanism to investigate potentially protective immune responses in the field.
first_indexed 2024-03-07T02:30:05Z
format Journal article
id oxford-uuid:a6f20d69-d707-43b6-959b-42ad552b593f
institution University of Oxford
language English
last_indexed 2024-03-07T02:30:05Z
publishDate 2004
record_format dspace
spelling oxford-uuid:a6f20d69-d707-43b6-959b-42ad552b593f2022-03-27T02:51:01ZCellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a6f20d69-d707-43b6-959b-42ad552b593fEnglishSymplectic Elements at Oxford2004Pinder, MReece, WPlebanski, MAkinwunmi, PFlanagan, KLee, EDoherty, TMilligan, PJaye, ATornieporth, NBallou, RMcAdam, KCohen, JHill, AVaccination of malaria-naive humans with recombinant RTS,S/AS02, which includes the C-terminus of the circumsporozoite protein (CS), has been shown to induce strong T cell responses to both the whole protein antigen and to peptides from CS. Here we show that strong T cell responses were also observed in a semi-immune population in The Gambia, West Africa. In a Phase I study, 20 adult male volunteers, lifelong residents in a malaria-endemic region, were given three doses of RTS,S/AS02 at 0, 1 and 6 months. Responses to RTS,S, hepatitis B surface antigen and peptides from CS were tested using lymphocyte proliferation, interferon (IFN)-gamma production in microcultures, and IFN-gamma ex vivo and cultured ELISPOT, before and after vaccination. Cytotoxic responses were tested only after vaccination and none were detected. Before vaccination, the majority of the volunteers (15/20) had detectable responses in at least one of the tests. After vaccination, responses increased in all assays except cytotoxicity. The increase was most marked for proliferation; all donors responded to RTS,S after the third dose and all except one donor responded to at least one peptide after the second or third dose. There was a lack of close association of peptide responses detected by the different assays, although in microcultures IFN-gamma responses were found only when proliferative responses were high, and responses by cultured ELISPOT and proliferation were found together more frequently after vaccination. We have therefore identified several peptide-specific T cell responses induced by RTS,S/AS02 which provides a mechanism to investigate potentially protective immune responses in the field.
spellingShingle Pinder, M
Reece, W
Plebanski, M
Akinwunmi, P
Flanagan, K
Lee, E
Doherty, T
Milligan, P
Jaye, A
Tornieporth, N
Ballou, R
McAdam, K
Cohen, J
Hill, A
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title_full Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title_fullStr Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title_full_unstemmed Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title_short Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.
title_sort cellular immunity induced by the recombinant plasmodium falciparum malaria vaccine rts s as02 in semi immune adults in the gambia
work_keys_str_mv AT pinderm cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT reecew cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT plebanskim cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT akinwunmip cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT flanagank cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT leee cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT dohertyt cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT milliganp cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT jayea cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT tornieporthn cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT ballour cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT mcadamk cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT cohenj cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia
AT hilla cellularimmunityinducedbytherecombinantplasmodiumfalciparummalariavaccinertssas02insemiimmuneadultsinthegambia